Katipally, Rohan R. http://orcid.org/0000-0003-4587-5444
Pitroda, Sean P.
Juloori, Aditya
Chmura, Steven J.
Weichselbaum, Ralph R.
Article History
Accepted: 1 June 2022
First Online: 12 July 2022
Competing interests
: S.P.P and R.R.W. are co-inventors on a patent entitled “Methods and kits for diagnosis and triage of patients with colorectal liver metastases” and on a provisional patent entitled “Molecular subtyping of colorectal liver metastases to personalize treatment approaches”. A.J. has served in a consulting role for Isoray. S.J.C. has participated on advisory boards for AstraZeneca and Genentech, receives research support from AstraZeneca, Bristol Myers Squibb, EMD Serono and Merck, and his spouse is employed as the medical director of Astellas Pharma. R.R.W. has stock and other ownership interests in Aqualung Therapeutics, Boost Therapeutics, Coordination Pharmaceuticals, Immvira LLC, Magi Therapeutics, Oncosenescence and Reflexion Pharmaceuticals; has served in a consulting or advisory role for Aettis, Aqualung Therapeutics, AstraZeneca, Coordination Pharmaceuticals, Genus, Highlight Therapeutics, Merck Serono, Nano Proteagen, NKMax America and Shuttle Pharmaceuticals; has received research grants from Regeneron and Varian; and has received compensation including travel, accommodation or expense reimbursement from AstraZeneca, Boehringer Ingelheim and Merck Serono.